Literature DB >> 24198456

EFFECTIVELY IMPLEMENTING PSYCHIATRIC ADVANCE DIRECTIVES TO PROMOTE SELF-DETERMINATION OF TREATMENT AMONG PEOPLE WITH MENTAL ILLNESS.

Eric B Elbogen1, Richard Van Dorn, Jeffrey W Swanson, Marvin S Swartz, Joelle Ferron, H Ryan Wagner, Christine Wilder.   

Abstract

Statutes on psychiatric advance directives (PADs) allow competent individuals to document instructions for future mental health treatment in the event of an incapacitating crisis. PADs are aimed at promoting a stronger sense of patient self-determination, considered a central tenet of psychosocial rehabilitation and recovery; however, it is unknown what factors (if any) lead psychiatric patients with PADs to experience this benefit long term. The current study involves examination of 1 year effects on perceived treatment self-determination among 125 people with mental disorders who completed PADs via a 1-on-1 facilitated PAD intervention. Descriptive analyses showed participants documented medically relevant information that would assist doctors in a crisis and participants reported a high level of satisfaction with the facilitated PAD intervention. Multivariate analyses demonstrated that increased sense of autonomy at 1 year was predicted by race, understanding PADs, and verbal memory. Results provide useful guidance for administrators and clinicians, suggesting that PADs show promise in helping empower people with mental illness, especially African-American clients. Further, findings indicate that optimal implementation of PADs will be achieved when facilitated intervention assists people with mental illness to better understand what PADs are and to remember they have a PAD at the time they are experiencing a psychiatric crisis.

Entities:  

Keywords:  mental health law; patient self-determination; psychiatric advance directives; psychiatric disabilities; psychosocial rehabilitation

Year:  2007        PMID: 24198456      PMCID: PMC3816514          DOI: 10.1037/1076-8971.13.4.273

Source DB:  PubMed          Journal:  Psychol Public Policy Law        ISSN: 1076-8971


  25 in total

1.  The MacArthur Treatment Competence Study. II: Measures of abilities related to competence to consent to treatment.

Authors:  Thomas Grisso; Paul S Appelbaum; Edward P Mulvey; Kenneth Fletcher
Journal:  Law Hum Behav       Date:  1995-04

Review 2.  Interventions to improve medication adherence in schizophrenia.

Authors:  Annette Zygmunt; Mark Olfson; Carol A Boyer; David Mechanic
Journal:  Am J Psychiatry       Date:  2002-10       Impact factor: 18.112

3.  Law & psychiatry: psychiatric advance directives and the treatment of committed patients.

Authors:  Paul S Appelbaum
Journal:  Psychiatr Serv       Date:  2004-07       Impact factor: 3.084

4.  Consumers' goals in psychiatric rehabilitation and their concordance with existing services.

Authors:  Tania Lecomte; Charles J Wallace; Michel Perreault; Jean Caron
Journal:  Psychiatr Serv       Date:  2005-02       Impact factor: 3.084

5.  Psychiatric advance directives.

Authors:  Kaustubh G Joshi
Journal:  J Psychiatr Pract       Date:  2003-07       Impact factor: 1.325

6.  Clinicians' attitudes regarding barriers to the implementation of psychiatric advance directives.

Authors:  Richard A Van Dorn; Marvin S Swartz; Eric B Elbogen; Jeffrey W Swanson; Mimi Kim; Joelle Ferron; Laura A McDaniel; Anna M Scheyett
Journal:  Adm Policy Ment Health       Date:  2006-07

7.  Psychiatric advance directives: an alternative to coercive treatment?

Authors:  J W Swanson; M C Tepper; P Backlar; M S Swartz
Journal:  Psychiatry       Date:  2000       Impact factor: 2.458

8.  Facilitated psychiatric advance directives: a randomized trial of an intervention to foster advance treatment planning among persons with severe mental illness.

Authors:  Jeffrey W Swanson; Marvin S Swartz; Eric B Elbogen; Richard A Van Dorn; Joelle Ferron; H Ryan Wagner; Barbara J McCauley; Mimi Kim
Journal:  Am J Psychiatry       Date:  2006-11       Impact factor: 18.112

9.  Initial motivations for alcohol treatment: relations with patient characteristics, treatment involvement, and dropout.

Authors:  R M Ryan; R W Plant; S O'Malley
Journal:  Addict Behav       Date:  1995 May-Jun       Impact factor: 3.913

10.  Clinical decision making and views about psychiatric advance directives.

Authors:  Eric B Elbogen; Marvin S Swartz; Richard Van Dorn; Jeffrey W Swanson; Mimi Kim; Anna Scheyett
Journal:  Psychiatr Serv       Date:  2006-03       Impact factor: 3.084

View more
  6 in total

1.  Medication preferences and adherence among individuals with severe mental illness and psychiatric advance directives.

Authors:  Christine M Wilder; Eric B Elbogen; Lorna L Moser; Jeffrey W Swanson; Marvin S Swartz
Journal:  Psychiatr Serv       Date:  2010-04       Impact factor: 3.084

Review 2.  Psychiatric advance directives and social workers: an integrative review.

Authors:  Richard A Van Dorn; Anna Scheyett; Jeffrey W Swanson; Marvin S Swartz
Journal:  Soc Work       Date:  2010-04

3.  Patient-Centered Values and Experiences with Emergency Department and Mental Health Crisis Care.

Authors:  Kathleen C Thomas; Hillary Owino; Sana Ansari; Leslie Adams; Julianne M Cyr; Bradley N Gaynes; Seth W Glickman
Journal:  Adm Policy Ment Health       Date:  2018-07

4.  Preferences for psychiatric advance directives among Latinos: views on advance care planning for mental health.

Authors:  Richard A Van Dorn; Jeffrey W Swanson; Marvin S Swartz
Journal:  Psychiatr Serv       Date:  2009-10       Impact factor: 3.084

5.  Psychiatric Advance Directives Under the Convention on the Rights of Persons With Disabilities: Why Advance Instructions Should Be Able to Override Current Preferences.

Authors:  Matthé Scholten; Astrid Gieselmann; Jakov Gather; Jochen Vollmann
Journal:  Front Psychiatry       Date:  2019-09-11       Impact factor: 4.157

6.  Psychiatric advance directives for people living with schizophrenia, bipolar I disorders, or schizoaffective disorders: Study protocol for a randomized controlled trial - DAiP study.

Authors:  Aurélie Tinland; Léa Leclerc; Sandrine Loubière; Frederic Mougeot; Tim Greacen; Magali Pontier; Nicolas Franck; Christophe Lançon; Mohamed Boucekine; Pascal Auquier
Journal:  BMC Psychiatry       Date:  2019-12-27       Impact factor: 3.630

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.